September 17, 2026: Knowing your Patient: Phenotyping IBD and Stratifying Risk to Guide Therapy
Thank you for attending the first session of this ECHO program!
Claiming Credit
Thank you for attending the session on September 17, 2026. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to claim your credit on the following page
Target Audience
This ECHO® series is designed for gastroenterologists, NPs, PAs, nurses, and pharmacists in community and academic GI practices. Teams and individual GI providers are welcome to attend!
Learning Objectives:
At the conclusion of this learning activity, participants will be better able to:
- Accurately classify a patient's IBD phenotype, predict disease behavior, and identify clinical and diagnostic features relevant to creating an appropriate therapy plan.
Grantor Acknowledgement:
Supported by educational grants from AbbVie, Celltrion USA, Janssen Biotech, administered by Janssen Scientific Affairs LLC, and Takeda Pharmaceuticals U.S.A.,Inc.
Disclaimer Policy
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.
Course summary
- 1.00 AAPA Category I CME
- 1.00 ABIM Medical Knowledge
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 ANCC
- 1.00 Participation

Sharmeel Kaur Wasan, MD
Course Director
Clinical Associate Professor of Medicine
Gastroenterology Fellowship Program Director
Boston Medical Center
Associate Professor of Medicine
Boston University Chobanian and Avedisian School of Medicine
Boston, MA
Sharmeel K Wasan, MD, FACG is a clinician-educator with an expertise in Inflammatory Bowel Diseases (IBD) and a Clinical Associate Professor of Medicine at Boston University. She completed her clinical training at Boston Medical Center, the Brigham and Women’s Hospital, and the University of Maryland. She received her BS in Biological Sciences and BA in Anthropology from Stanford University in Palo Alto, CA and received her MD from Albert Einstein College of Medicine in New York.
As the Gastroenterology Fellowship Program Director at Boston Medical Center, she is actively involved in the training of fellows, residents, and medical students. Her research focuses on advancing health equity in IBD by addressing disparities and improving access to clinical trials and emerging therapies for underserved populations. Other research interests include vaccination strategies, health care maintenance in patients with IBD, and educational strategies in endoscopy training. She has received research and educational grants from BU and from industry supported funding.
Dr. Sharmeel Wasan has no relevant financial relationships to disclose.
Off-Label Discussion: The speaker does not plan on discussing unlabeled/investigational uses of a commercial product.
Planning Committee
The following planning committee members have no relevant financial relationships to disclose.
- Linda Baer, MSPH, CHCP; BU CCE Associate Director
- Juanita Belton, PA; BU CCE’s Physician Associate Accreditation Reviewer
- Michael Burk, BS; BU CCE Senior Operations Manager
- Elizabeth Drury, BA, BU CCE Assistant Director, Compliance
- Amy Donegan, APRN, CPNP-PC; Member of the BU Hub Team and Nursing Accreditation Advisor
- Sharmeel Wasan, MD; Program Course Director
Dr. Spiewak, PharmD, MCSR-RPh, MSCS; ACPE Accreditation Advisor, discloses that he is a speaker, consultant, and on the advisory panels for Abbvie, Celltrion, and Johnson & Johnson.
Disclosure Policy
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.
Accreditation Statement
This activity is developed by Boston University Chobanian & Avedisian School of Medicine.

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Accreditation
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Internal Medicine Maintenance of Certification (MOC) Part 2 Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By participating and claiming credit, you agree to BU sharing your information with ACCME PARS the data conduit to the ABIM.
Nurse Accreditation
Nursing Contact Hours: 1.0, of which none of which is eligible for pharmacology credit.
Physician Associate Accreditation

Boston University Chobanian & Avedisian School of Medicine has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Pharmacy Accreditation

This activity is approved for 1.0 CPE credit(s) under the ACPE universal activity number UAN JA0000185-0000-26-041-L01-P. The activity is available for credit claiming through 11/16/26.
IPCE Accreditation
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change.
Questions: If you have any questions about the program, registering or claiming credit please write [email protected] and your questions will be answered.
Available Credit
- 1.00 AAPA Category I CME
- 1.00 ABIM Medical Knowledge
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 ANCC
- 1.00 Participation

Facebook
X
LinkedIn
Forward